Malignant melanoma of the vulva is a rare malignant disease. Women in their 50s, 60s, and 70s are predominantly affected. The clinical presentation can be in the form of an asymptomatic pigmented lesion, or with manifestations of vaginal bleeding, discharge, local pain, itching, and urinary discomfort. The disease has the aggressive nature and poor prognosis. A detailed physical examination followed by a histopathological evaluation of the lesion is crucial for making the diagnosis.
Malignant melanoma of the vulva often has an insidious course and carries a poor prognosis because of its high potential for spreading to distant tissues   . One of its peculiar characteristics is the absence of ultraviolet (UV) light exposure as a risk factor  . This rare tumor (< 5% of all melanomas in women) most often presents as an asymptomatic pigmented lesion, with the principal locations being the labia majora and the clitoral region, but the labia minora, the periurethral area, and, very rarely, the introitus of the vagina are also possible locations   . The glabrous skin is much more frequently the site of malignant melanoma of the vulva compared to hairy skin . When manifestations are present, vaginal bleeding is reported as the most common, whereas vaginal discharge, pruritus, pain, vaginal irritation, and a stinging sensation are other notable symptoms and signs    . Weight loss may be reported in some cases . Malignant melanoma of the vulva is mainly identified in elderly women in their sixth, seventh, and eighth decades of life   .
Entire Body System
Weight loss may be reported in some cases. Malignant melanoma of the vulva is mainly identified in elderly women in their sixth, seventh, and eighth decades of life. [symptoma.com]
Symptoms of recurrent cancer may include bleeding, pain in the genitals, groin, pelvis or legs, leg swelling (edema), weight loss, chronic cough and chest pain. [womenscancercenter.com]
Other symptoms described in the literature are weight loss and secondary anemia. 7 Small bowel is the election site of cutaneous melanomas metastasis, so the presence of a melanocytic tumor at this level should alert gastroenterologists to search for [dovepress.com]
Histopathologic specimens and clinical histories of the 198 patients who qualified for this study were reanalyzed and the tumors rigorously subtyped. [ncbi.nlm.nih.gov]
The clinical presentation can be in the form of an asymptomatic pigmented lesion, or with manifestations of vaginal bleeding, discharge, local pain, itching, and urinary discomfort. The disease has the aggressive nature and poor prognosis. [symptoma.com]
The cytologic diagnosis of metastatic vulvar melanoma from peritoneal effusions has not been previously described. [ncbi.nlm.nih.gov]
Clinically, sarcoma may present as a subcutaneous nodule or may be exophytic and fleshy. Prognosis is usually poor and depends on histologic type, extent of local invasion, and treatment. [health.am]
Stage II included tumors with a spread to the regional lymph nodes and also cutaneous or subcutaneous nodules more than 2 cm from the primary tumor but not beyond the site of the primary lymph node drainage (i.e., in‐transit metastases). [onlinelibrary.wiley.com]
angiokeratoma on the vulva that was misdiagnosed as malignant melanoma. [mdedge.com]
[…] mitosis and other features of melanoma including ulceration Pigmented epidermal neoplasms, including seborrheic keratosis, vulvar intraepithelial neoplasia, condyloma, basal cell carcinoma Postinflammatory pigmentary alteration Vascular lesions, such as angiokeratoma [pathologyoutlines.com]
A detailed patient history and a full physical examination are crucial steps of the workup for patients in whom malignant melanoma of the vulva is suspected. Signs and symptoms are often missed during the initial workup , which may significantly affect the prognosis and the efficacy of therapy. The physician must ask about the presence of vaginal-related symptoms, such as bleeding, discharge, or pruritus, whereas a detailed genital examination is necessary to identify a pigmented lesion. The exact type of tumor must be identified as soon as the lesion is detected and a biopsy with subsequent histopathological examination is vital in this regard    . Typical mutations include C-KIT and NRAS genes, whereas BRAF gene mutations are rarely seen . When a suspicion toward the existence of metastases exists (the urethra, vagina, perianal area, regional and distant lymph nodes, liver, and lungs are frequently involved locations), imaging studies need to be conducted in order to determine the extent of tumor spread  . Positron emission tomography-computed tomography (PET-CT) is regarded as the optimal study for evaluating metastatic malignant melanoma of the vulva .
- Chokoeva A, Tchernev G, Wollina U. Vulvar melanoma [Article in Bulgarian] Akush Ginekol (Sofiia). 2015;54(2):56-60.
- Ragnarsson-Olding BK. Primary malignant melanoma of the vulva--an aggressive tumor for modeling the genesis of non-UV light-associated melanomas. Acta Oncol. 2004;43(5):421-435.
- Androutsopoulos G, Terzakis E, Ioannidou G, et al. Vaginal primary malignant melanoma: a rare and aggressive tumor. Case Rep Obstet Gynecol 2013;2013:137908.
- Skovsted S, Nielsen K, Blaakær J. Melanomas of the vulva and vagina. Dan Med J. 2017;64(3). pii: A5336.
- Aulmann S, Sinn HP, Penzel R, et al. Comparison of molecular abnormalities in vulvar and vaginal melanomas. Mod Pathol 2014;27:1386-1393.
- Lemańska A, Banach P, Magnowska M, Frankowski A, Nowak-Markwitz E, Spaczyński M. Vulvar melanoma with urethral invasion and bladder metastases – a case report and review of the literature. Arch Med Sci. 2015;11(1):240-252.
- Verschraegen CF, Benjapibal M, Supakarapongkul W, et al. Vulvar melanoma at the M. D. Anderson Cancer Center: 25 years later. Int J Gynecol Cancer. 2001;11:359–364
- Baiocchi G, Duprat JP, Neves RI, et al. Vulvar melanoma: report on eleven cases and review of the literature. Sao Paulo Med J. 2010;128:38–41.
- Rouzbahman M, Kamel-Reid S, Al Habeeb A, et al. Malignant Melanoma of Vulva and Vagina: A Histomorphological Review and Mutation Analysis--A Single-Center Study. J Low Genit Tract Dis. 2015;19(4):350-353.
- Frumovitz M, Etchepareborda M, Sun CC, et al. Primary malignant melanoma of the vagina. Obstet Gynecol 2010;116:1358-1365.